Waters Corporation Surges to 82nd in Trading Volume with $1.024 Billion Day Amid Strategic Acquisition

On July 14, 2025, Waters Corporation (WAT) experienced a significant trading volume of $1.024 billion, marking a 412.33% increase from the previous day. This surge placed Waters at the 82nd position in terms of trading volume for the day. However, the stock price of Waters declined by 13.81%, marking the second consecutive day of decline, with a total decrease of 13.90% over the past two days.

Waters Corporation has announced a strategic acquisition of Becton Dickinson's Biosciences & Diagnostic Solutions business. This deal, valued at $17.5 billion, aims to create a leading life science and diagnostics company focused on regulated, high-volume testing. The combined entity will leverage complementary technologies to serve attractive and regulated end-markets, offering best-in-class liquid chromatography, mass spectrometry, flow cytometry, and diagnostic solutions.

Under the terms of the agreement, Becton Dickinson's division will be spun off to its shareholders and simultaneously merged with a wholly-owned subsidiary of Waters. This transaction is expected to be tax-free and is anticipated to be completed in the first quarter of next year. Waters shareholders will hold a 60.8% stake in the combined firm, while Becton Dickinson investors will hold the remaining 39.2%.

Waters Corporation's Chairman, Dr. Flemming Ornskov, highlighted the strategic fit of the merger, noting that it will accelerate the company's strategy in multiple high-growth markets and deliver substantial near- and long-term value to shareholders. The acquisition is expected to double Waters' total addressable market and boost its recurring revenue, providing additional benefits to the company.